Journal article
Functional parameters derived from magnetic resonance imaging reflect vascular 1 morphology in preclinical tumors and in human liver metastases
- Abstract:
-
Purpose: Tumor vessels influence the growth and response of tumors to therapy. Imaging vascular changes in vivo using dynamic contrast-enhanced MRI (DCE-MRI) has shown potential to guide clinical decision making for treatment. However, quantitative MR imaging biomarkers of vascular function have not been widely adopted, partly because their relationship to structural changes in vessels remains unclear. We aimed to elucidate the relationships between vessel function and morphology in vivo.
Experimental Design: Untreated preclinical tumors with different levels of vascularization were imaged sequentially using DCE-MRI and CT. Relationships between functional parameters from MR (iAUC, Ktrans, and BATfrac) and structural parameters from CT (vessel volume, radius, and tortuosity) were assessed using linear models. Tumors treated with anti-VEGFR2 antibody were then imaged to determine whether antiangiogenic therapy altered these relationships. Finally, functional–structural relationships were measured in 10 patients with liver metastases from colorectal cancer.
Results: Functional parameters iAUC and Ktrans primarily reflected vessel volume in untreated preclinical tumors. The relationships varied spatially and with tumor vascularity, and were altered by antiangiogenic treatment. In human liver metastases, all three structural parameters were linearly correlated with iAUC and Ktrans. For iAUC, structural parameters also modified each other's effect.
Conclusions: Our findings suggest that MR imaging biomarkers of vascular function are linked to structural changes in tumor vessels and that antiangiogenic therapy can affect this link. Our work also demonstrates the feasibility of three-dimensional functional–structural validation of MR biomarkers in vivo to improve their biological interpretation and clinical utility.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 9.3MB, Terms of use)
-
- Publisher copy:
- 10.1158/1078-0432.CCR-18-0033
Authors
- Publisher:
- American Association for Cancer Research
- Journal:
- Clinical Cancer Research More from this journal
- Volume:
- 24
- Issue:
- 19
- Pages:
- 4694–4704
- Publication date:
- 2018-06-29
- Acceptance date:
- 2018-06-25
- DOI:
- EISSN:
-
1557-3265
- ISSN:
-
1078-0432
- Keywords:
- Pubs id:
-
pubs:856975
- UUID:
-
uuid:b8d4fb4e-77bc-4be7-b6f1-981050303798
- Local pid:
-
pubs:856975
- Source identifiers:
-
856975
- Deposit date:
-
2018-06-11
Terms of use
- Copyright holder:
- American Association for Cancer Research
- Copyright date:
- 2018
- Notes:
- Copyright © 2018 American Association for Cancer Research. This is the accepted manuscript version of the article. The final version is available online from American Association for Cancer Research at: https://doi.org/10.1158/1078-0432.CCR-18-0033
If you are the owner of this record, you can report an update to it here: Report update to this record